APO Research
Talk to an analyst

APO RESEARCH · REPORT

Bipolar Disorder Medications

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Bipolar Disorder Medications Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

20 December 2025199 pages

Choose your research edition.

Industry ResearchBipolar Disorder Medications Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Bipolar Disorder Medications Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Bipolar Disorder Medications Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bipolar Disorder Medications Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Bipolar Disorder Medications Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Bipolar Disorder Medications market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Bipolar Disorder Medications is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Bipolar Disorder Medications is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Bipolar Disorder Medications is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Bipolar Disorder Medications is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Bipolar Disorder Medications include Janssen Pharmaceuticals, Johnson & Johnson, Novartis AG, Eli Lily and Company, Pfizer Inc., Glaxo SmithKline (GSK), AbbVie Inc., Validus Pharmaceuticals LLC. and Otsuka Holdings Co. Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Bipolar Disorder Medications market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Bipolar Disorder Medications and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Bipolar Disorder Medications sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Bipolar Disorder Medications market size, projected growth trends, production technologies, key applications, and end-use industries.

Bipolar Disorder Medications Segment by Company

Janssen Pharmaceuticals

Johnson & Johnson

Novartis AG

Eli Lily and Company

Pfizer Inc.

Glaxo SmithKline (GSK)

AbbVie Inc.

Validus Pharmaceuticals LLC.

Otsuka Holdings Co. Ltd

H. Lundbeck A/S

Gedeon Richter PLC.

Bristol Myers Squibb

Astellas Pharma Inc

Bipolar Disorder Medications Segment by Type

Anti-Anxiety Drugs

Anticonvulsants

Antipsychotic Drugs

Antidepressant Drugs

Mood Stabilizers

Bipolar Disorder Medications Segment by Application

Hospital

Clinic

Bipolar Disorder Medications Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bipolar Disorder Medications market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bipolar Disorder Medications and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bipolar Disorder Medications.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Bipolar Disorder Medications market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Bipolar Disorder Medications manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Bipolar Disorder Medications in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Bipolar Disorder Medications in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Bipolar Disorder Medications Industry Trends Table 2. Bipolar Disorder Medications Industry Drivers Table 3. Bipolar Disorder Medications Industry Opportunities and Challenges Table 4. Bipolar Disorder Medications Industry Restraints Table 5. Global Bipolar Disorder Medications Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Bipolar Disorder Medications Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Bipolar Disorder Medications Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Bipolar Disorder Medications Sales Market Share by Manufacturers Table 9. Global Bipolar Disorder Medications Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Bipolar Disorder Medications Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Bipolar Disorder Medications Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Bipolar Disorder Medications Manufacturers, Product Type & Application Table 13. Global Bipolar Disorder Medications Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Bipolar Disorder Medications by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Anti-Anxiety Drugs Table 17. Major Manufacturers of Anticonvulsants Table 18. Major Manufacturers of Antipsychotic Drugs Table 19. Major Manufacturers of Antidepressant Drugs Table 20. Major Manufacturers of Mood Stabilizers Table 21. Global Bipolar Disorder Medications Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Bipolar Disorder Medications Sales by Type (2021-2026) & (K Units) Table 23. Global Bipolar Disorder Medications Sales by Type (2027-2032) & (K Units) Table 24. Global Bipolar Disorder Medications Sales Market Share by Type (2021-2026) Table 25. Global Bipolar Disorder Medications Sales Market Share by Type (2027-2032) Table 26. Global Bipolar Disorder Medications Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 27. Global Bipolar Disorder Medications Revenue by Type (2021-2026) & (K Units) Table 28. Global Bipolar Disorder Medications Revenue by Type (2027-2032) & (K Units) Table 29. Global Bipolar Disorder Medications Revenue Market Share by Type (2021-2026) Table 30. Global Bipolar Disorder Medications Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Hospital Table 32. Major Manufacturers of Clinic Table 33. Global Bipolar Disorder Medications Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Bipolar Disorder Medications Sales by Application (2021-2026) & (K Units) Table 35. Global Bipolar Disorder Medications Sales by Application (2027-2032) & (K Units) Table 36. Global Bipolar Disorder Medications Sales Market Share by Application (2021-2026) Table 37. Global Bipolar Disorder Medications Sales Market Share by Application (2027-2032) Table 38. Global Bipolar Disorder Medications Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global Bipolar Disorder Medications Revenue by Application (2021-2026) & (K Units) Table 40. Global Bipolar Disorder Medications Revenue by Application (2027-2032) & (K Units) Table 41. Global Bipolar Disorder Medications Revenue Market Share by Application (2021-2026) Table 42. Global Bipolar Disorder Medications Revenue Market Share by Application (2027-2032) Table 43. Global Bipolar Disorder Medications Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Bipolar Disorder Medications Sales by Region (2021-2026) & (K Units) Table 45. Global Bipolar Disorder Medications Sales Market Share by Region (2021-2026) Table 46. Global Bipolar Disorder Medications Sales Forecasted by Region (2027-2032) & (K Units) Table 47. Global Bipolar Disorder Medications Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Bipolar Disorder Medications Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. North America Bipolar Disorder Medications Sales by Country (2021-2026) & (K Units) Table 50. North America Bipolar Disorder Medications Sales by Country (2027-2032) & (K Units) Table 51. Europe Bipolar Disorder Medications Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Europe Bipolar Disorder Medications Sales by Country (2021-2026) & (K Units) Table 53. Europe Bipolar Disorder Medications Sales by Country (2027-2032) & (K Units) Table 54. Asia Pacific Bipolar Disorder Medications Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Asia Pacific Bipolar Disorder Medications Sales by Country (2021-2026) & (K Units) Table 56. Asia Pacific Bipolar Disorder Medications Sales by Country (2027-2032) & (K Units) Table 57. South America, Middle East and Africa Bipolar Disorder Medications Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. South America, Middle East and Africa Bipolar Disorder Medications Sales by Country (2021-2026) & (K Units) Table 59. South America, Middle East and Africa Bipolar Disorder Medications Sales by Country (2027-2032) & (K Units) Table 60. Global Bipolar Disorder Medications Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Bipolar Disorder Medications Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Bipolar Disorder Medications Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Bipolar Disorder Medications Revenue Market Share by Region (2021-2026) Table 64. Global Bipolar Disorder Medications Revenue Market Share by Region (2027-2032) Table 65. Janssen Pharmaceuticals Company Information Table 66. Janssen Pharmaceuticals Business Overview Table 67. Janssen Pharmaceuticals Bipolar Disorder Medications Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Janssen Pharmaceuticals Bipolar Disorder Medications Product Portfolio Table 69. Janssen Pharmaceuticals Recent Development Table 70. Johnson & Johnson Company Information Table 71. Johnson & Johnson Business Overview Table 72. Johnson & Johnson Bipolar Disorder Medications Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Johnson & Johnson Bipolar Disorder Medications Product Portfolio Table 74. Johnson & Johnson Recent Development Table 75. Novartis AG Company Information Table 76. Novartis AG Business Overview Table 77. Novartis AG Bipolar Disorder Medications Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Novartis AG Bipolar Disorder Medications Product Portfolio Table 79. Novartis AG Recent Development Table 80. Eli Lily and Company Company Information Table 81. Eli Lily and Company Business Overview Table 82. Eli Lily and Company Bipolar Disorder Medications Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Eli Lily and Company Bipolar Disorder Medications Product Portfolio Table 84. Eli Lily and Company Recent Development Table 85. Pfizer Inc. Company Information Table 86. Pfizer Inc. Business Overview Table 87. Pfizer Inc. Bipolar Disorder Medications Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Pfizer Inc. Bipolar Disorder Medications Product Portfolio Table 89. Pfizer Inc. Recent Development Table 90. Glaxo SmithKline (GSK) Company Information Table 91. Glaxo SmithKline (GSK) Business Overview Table 92. Glaxo SmithKline (GSK) Bipolar Disorder Medications Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Glaxo SmithKline (GSK) Bipolar Disorder Medications Product Portfolio Table 94. Glaxo SmithKline (GSK) Recent Development Table 95. AbbVie Inc. Company Information Table 96. AbbVie Inc. Business Overview Table 97. AbbVie Inc. Bipolar Disorder Medications Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. AbbVie Inc. Bipolar Disorder Medications Product Portfolio Table 99. AbbVie Inc. Recent Development Table 100. Validus Pharmaceuticals LLC. Company Information Table 101. Validus Pharmaceuticals LLC. Business Overview Table 102. Validus Pharmaceuticals LLC. Bipolar Disorder Medications Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Validus Pharmaceuticals LLC. Bipolar Disorder Medications Product Portfolio Table 104. Validus Pharmaceuticals LLC. Recent Development Table 105. Otsuka Holdings Co. Ltd Company Information Table 106. Otsuka Holdings Co. Ltd Business Overview Table 107. Otsuka Holdings Co. Ltd Bipolar Disorder Medications Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Otsuka Holdings Co. Ltd Bipolar Disorder Medications Product Portfolio Table 109. Otsuka Holdings Co. Ltd Recent Development Table 110. H. Lundbeck A/S Company Information Table 111. H. Lundbeck A/S Business Overview Table 112. H. Lundbeck A/S Bipolar Disorder Medications Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. H. Lundbeck A/S Bipolar Disorder Medications Product Portfolio Table 114. H. Lundbeck A/S Recent Development Table 115. Gedeon Richter PLC. Company Information Table 116. Gedeon Richter PLC. Business Overview Table 117. Gedeon Richter PLC. Bipolar Disorder Medications Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. Gedeon Richter PLC. Bipolar Disorder Medications Product Portfolio Table 119. Gedeon Richter PLC. Recent Development Table 120. Bristol Myers Squibb Company Information Table 121. Bristol Myers Squibb Business Overview Table 122. Bristol Myers Squibb Bipolar Disorder Medications Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. Bristol Myers Squibb Bipolar Disorder Medications Product Portfolio Table 124. Bristol Myers Squibb Recent Development Table 125. Astellas Pharma Inc Company Information Table 126. Astellas Pharma Inc Business Overview Table 127. Astellas Pharma Inc Bipolar Disorder Medications Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 128. Astellas Pharma Inc Bipolar Disorder Medications Product Portfolio Table 129. Astellas Pharma Inc Recent Development Table 130. Key Raw Materials Table 131. Raw Materials Key Suppliers Table 132. Bipolar Disorder Medications Distributors List Table 133. Bipolar Disorder Medications Customers List Table 134. Research Programs/Design for This Report Table 135. Authors List of This Report Table 136. Secondary Sources Table 137. Primary Sources List of Figures Figure 1. Bipolar Disorder Medications Product Image Figure 2. Global Bipolar Disorder Medications Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bipolar Disorder Medications Market Size (2021-2032) & (US$ Million) Figure 4. Global Bipolar Disorder Medications Sales (2021-2032) & (K Units) Figure 5. Global Bipolar Disorder Medications Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Bipolar Disorder Medications Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Anti-Anxiety Drugs Image Figure 9. Anticonvulsants Image Figure 10. Antipsychotic Drugs Image Figure 11. Antidepressant Drugs Image Figure 12. Mood Stabilizers Image Figure 13. Global Bipolar Disorder Medications Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Bipolar Disorder Medications Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Bipolar Disorder Medications Sales Market Share by Type (2021-2032) Figure 16. Global Bipolar Disorder Medications Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 17. Global Bipolar Disorder Medications Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Bipolar Disorder Medications Revenue Market Share by Type (2021-2032) Figure 19. Hospital Image Figure 20. Clinic Image Figure 21. Global Bipolar Disorder Medications Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Bipolar Disorder Medications Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Bipolar Disorder Medications Sales Market Share by Application (2021-2032) Figure 24. Global Bipolar Disorder Medications Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Bipolar Disorder Medications Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Bipolar Disorder Medications Revenue Market Share by Application (2021-2032) Figure 27. North America Bipolar Disorder Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 28. North America Bipolar Disorder Medications Sales Market Share by Country (2021-2032) Figure 29. U.S. Bipolar Disorder Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Canada Bipolar Disorder Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Mexico Bipolar Disorder Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Bipolar Disorder Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Bipolar Disorder Medications Sales Market Share by Country (2021-2032) Figure 34. Germany Bipolar Disorder Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 35. France Bipolar Disorder Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 36. U.K. Bipolar Disorder Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Italy Bipolar Disorder Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Netherlands Bipolar Disorder Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Bipolar Disorder Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Bipolar Disorder Medications Sales Market Share by Country (2021-2032) Figure 41. China Bipolar Disorder Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Japan Bipolar Disorder Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 43. South Korea Bipolar Disorder Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Southeast Asia Bipolar Disorder Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 45. India Bipolar Disorder Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Australia Bipolar Disorder Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Bipolar Disorder Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Bipolar Disorder Medications Sales Market Share by Country (2021-2032) Figure 49. Brazil Bipolar Disorder Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South Africa Bipolar Disorder Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Saudi Arabia Bipolar Disorder Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Turkey Bipolar Disorder Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Argentina Bipolar Disorder Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 54. UAE Bipolar Disorder Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Egypt Bipolar Disorder Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Chile Bipolar Disorder Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Global Bipolar Disorder Medications Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Bipolar Disorder Medications Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Bipolar Disorder Medications Revenue (2021-2032) & (US$ Million) Figure 60. North America Bipolar Disorder Medications Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Bipolar Disorder Medications Revenue (2021-2032) & (US$ Million) Figure 62. Europe Bipolar Disorder Medications Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Bipolar Disorder Medications Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Bipolar Disorder Medications Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Bipolar Disorder Medications Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Bipolar Disorder Medications Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Bipolar Disorder Medications Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Bipolar Disorder Medications Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Anti-Anxiety Drugs
  • Anticonvulsants
  • Antipsychotic Drugs
  • Antidepressant Drugs
  • Mood Stabilizers
Applications
  • Hospital
  • Clinic
Companies covered
  • Janssen Pharmaceuticals
  • Johnson & Johnson
  • Novartis AG
  • Eli Lily and Company
  • Pfizer Inc.
  • Glaxo SmithKline (GSK)
  • AbbVie Inc.
  • Validus Pharmaceuticals LLC.
  • Otsuka Holdings Co. Ltd
  • H. Lundbeck A/S
  • Gedeon Richter PLC.
  • Bristol Myers Squibb
  • Astellas Pharma Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Bipolar Disorder Medications Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Bipolar Disorder Medications Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Bipolar Disorder Medications Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Bipolar Disorder Medications Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Bipolar Disorder Medications Market Dynamics
  1. 2.1 Bipolar Disorder Medications Industry Trends
  2. 2.2 Bipolar Disorder Medications Industry Drivers
  3. 2.3 Bipolar Disorder Medications Industry Opportunities and Challenges
  4. 2.4 Bipolar Disorder Medications Industry Restraints
3 Bipolar Disorder Medications Market by Manufacturers
  1. 3.1 Global Bipolar Disorder Medications Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Bipolar Disorder Medications Sales by Manufacturers (2021-2026)
  3. 3.3 Global Bipolar Disorder Medications Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Bipolar Disorder Medications Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Bipolar Disorder Medications Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Bipolar Disorder Medications Manufacturers, Product Type & Application
  7. 3.7 Global Bipolar Disorder Medications Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Bipolar Disorder Medications Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Bipolar Disorder Medications Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Bipolar Disorder Medications Tier 1, Tier 2, and Tier 3
4 Bipolar Disorder Medications Market by Type
  1. 4.1 Bipolar Disorder Medications Type Introduction
  2. 4.1.1 Anti-Anxiety Drugs
  3. 4.1.2 Anticonvulsants
  4. 4.1.3 Antipsychotic Drugs
  5. 4.1.4 Antidepressant Drugs
  6. 4.1.5 Mood Stabilizers
  7. 4.2 Global Bipolar Disorder Medications Sales by Type
  8. 4.2.1 Global Bipolar Disorder Medications Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Bipolar Disorder Medications Sales by Type (2021-2032)
  10. 4.2.3 Global Bipolar Disorder Medications Sales Market Share by Type (2021-2032)
  11. 4.3 Global Bipolar Disorder Medications Revenue by Type
  12. 4.3.1 Global Bipolar Disorder Medications Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Bipolar Disorder Medications Revenue by Type (2021-2032)
  14. 4.3.3 Global Bipolar Disorder Medications Revenue Market Share by Type (2021-2032)
5 Bipolar Disorder Medications Market by Application
  1. 5.1 Bipolar Disorder Medications Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Bipolar Disorder Medications Sales by Application
  5. 5.2.1 Global Bipolar Disorder Medications Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Bipolar Disorder Medications Sales by Application (2021-2032)
  7. 5.2.3 Global Bipolar Disorder Medications Sales Market Share by Application (2021-2032)
  8. 5.3 Global Bipolar Disorder Medications Revenue by Application
  9. 5.3.1 Global Bipolar Disorder Medications Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Bipolar Disorder Medications Revenue by Application (2021-2032)
  11. 5.3.3 Global Bipolar Disorder Medications Revenue Market Share by Application (2021-2032)
6 Global Bipolar Disorder Medications Sales by Region
  1. 6.1 Global Bipolar Disorder Medications Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Bipolar Disorder Medications Sales by Region (2021-2032)
  3. 6.2.1 Global Bipolar Disorder Medications Sales by Region (2021-2026)
  4. 6.2.2 Global Bipolar Disorder Medications Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Bipolar Disorder Medications Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Bipolar Disorder Medications Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Bipolar Disorder Medications Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Bipolar Disorder Medications Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Bipolar Disorder Medications Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Bipolar Disorder Medications Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Bipolar Disorder Medications Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Bipolar Disorder Medications Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Bipolar Disorder Medications Revenue by Region
  1. 7.1 Global Bipolar Disorder Medications Revenue by Region
  2. 7.1.1 Global Bipolar Disorder Medications Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Bipolar Disorder Medications Revenue by Region (2021-2026)
  4. 7.1.3 Global Bipolar Disorder Medications Revenue by Region (2027-2032)
  5. 7.1.4 Global Bipolar Disorder Medications Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Bipolar Disorder Medications Revenue (2021-2032)
  8. 7.2.2 North America Bipolar Disorder Medications Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Bipolar Disorder Medications Revenue (2021-2032)
  11. 7.3.2 Europe Bipolar Disorder Medications Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Bipolar Disorder Medications Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Bipolar Disorder Medications Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Bipolar Disorder Medications Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Bipolar Disorder Medications Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Janssen Pharmaceuticals
  2. 8.1.1 Janssen Pharmaceuticals Company Information
  3. 8.1.2 Janssen Pharmaceuticals Business Overview
  4. 8.1.3 Janssen Pharmaceuticals Bipolar Disorder Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Janssen Pharmaceuticals Bipolar Disorder Medications Product Portfolio
  6. 8.1.5 Janssen Pharmaceuticals Recent Developments
  7. 8.2 Johnson & Johnson
  8. 8.2.1 Johnson & Johnson Company Information
  9. 8.2.2 Johnson & Johnson Business Overview
  10. 8.2.3 Johnson & Johnson Bipolar Disorder Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Johnson & Johnson Bipolar Disorder Medications Product Portfolio
  12. 8.2.5 Johnson & Johnson Recent Developments
  13. 8.3 Novartis AG
  14. 8.3.1 Novartis AG Company Information
  15. 8.3.2 Novartis AG Business Overview
  16. 8.3.3 Novartis AG Bipolar Disorder Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Novartis AG Bipolar Disorder Medications Product Portfolio
  18. 8.3.5 Novartis AG Recent Developments
  19. 8.4 Eli Lily and Company
  20. 8.4.1 Eli Lily and Company Company Information
  21. 8.4.2 Eli Lily and Company Business Overview
  22. 8.4.3 Eli Lily and Company Bipolar Disorder Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Eli Lily and Company Bipolar Disorder Medications Product Portfolio
  24. 8.4.5 Eli Lily and Company Recent Developments
  25. 8.5 Pfizer Inc.
  26. 8.5.1 Pfizer Inc. Company Information
  27. 8.5.2 Pfizer Inc. Business Overview
  28. 8.5.3 Pfizer Inc. Bipolar Disorder Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Pfizer Inc. Bipolar Disorder Medications Product Portfolio
  30. 8.5.5 Pfizer Inc. Recent Developments
  31. 8.6 Glaxo SmithKline (GSK)
  32. 8.6.1 Glaxo SmithKline (GSK) Company Information
  33. 8.6.2 Glaxo SmithKline (GSK) Business Overview
  34. 8.6.3 Glaxo SmithKline (GSK) Bipolar Disorder Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Glaxo SmithKline (GSK) Bipolar Disorder Medications Product Portfolio
  36. 8.6.5 Glaxo SmithKline (GSK) Recent Developments
  37. 8.7 AbbVie Inc.
  38. 8.7.1 AbbVie Inc. Company Information
  39. 8.7.2 AbbVie Inc. Business Overview
  40. 8.7.3 AbbVie Inc. Bipolar Disorder Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 AbbVie Inc. Bipolar Disorder Medications Product Portfolio
  42. 8.7.5 AbbVie Inc. Recent Developments
  43. 8.8 Validus Pharmaceuticals LLC.
  44. 8.8.1 Validus Pharmaceuticals LLC. Company Information
  45. 8.8.2 Validus Pharmaceuticals LLC. Business Overview
  46. 8.8.3 Validus Pharmaceuticals LLC. Bipolar Disorder Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Validus Pharmaceuticals LLC. Bipolar Disorder Medications Product Portfolio
  48. 8.8.5 Validus Pharmaceuticals LLC. Recent Developments
  49. 8.9 Otsuka Holdings Co. Ltd
  50. 8.9.1 Otsuka Holdings Co. Ltd Company Information
  51. 8.9.2 Otsuka Holdings Co. Ltd Business Overview
  52. 8.9.3 Otsuka Holdings Co. Ltd Bipolar Disorder Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Otsuka Holdings Co. Ltd Bipolar Disorder Medications Product Portfolio
  54. 8.9.5 Otsuka Holdings Co. Ltd Recent Developments
  55. 8.10 H. Lundbeck A/S
  56. 8.10.1 H. Lundbeck A/S Company Information
  57. 8.10.2 H. Lundbeck A/S Business Overview
  58. 8.10.3 H. Lundbeck A/S Bipolar Disorder Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 H. Lundbeck A/S Bipolar Disorder Medications Product Portfolio
  60. 8.10.5 H. Lundbeck A/S Recent Developments
  61. 8.11 Gedeon Richter PLC.
  62. 8.11.1 Gedeon Richter PLC. Company Information
  63. 8.11.2 Gedeon Richter PLC. Business Overview
  64. 8.11.3 Gedeon Richter PLC. Bipolar Disorder Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Gedeon Richter PLC. Bipolar Disorder Medications Product Portfolio
  66. 8.11.5 Gedeon Richter PLC. Recent Developments
  67. 8.12 Bristol Myers Squibb
  68. 8.12.1 Bristol Myers Squibb Company Information
  69. 8.12.2 Bristol Myers Squibb Business Overview
  70. 8.12.3 Bristol Myers Squibb Bipolar Disorder Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Bristol Myers Squibb Bipolar Disorder Medications Product Portfolio
  72. 8.12.5 Bristol Myers Squibb Recent Developments
  73. 8.13 Astellas Pharma Inc
  74. 8.13.1 Astellas Pharma Inc Company Information
  75. 8.13.2 Astellas Pharma Inc Business Overview
  76. 8.13.3 Astellas Pharma Inc Bipolar Disorder Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Astellas Pharma Inc Bipolar Disorder Medications Product Portfolio
  78. 8.13.5 Astellas Pharma Inc Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Bipolar Disorder Medications Value Chain Analysis
  2. 9.1.1 Bipolar Disorder Medications Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Bipolar Disorder Medications Production Mode & Process
  6. 9.2 Bipolar Disorder Medications Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Bipolar Disorder Medications Distributors
  9. 9.2.3 Bipolar Disorder Medications Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst